Geraldine Pannu, Director at Processa Pharmaceuticals, Inc. (PCSA), bought 2,072 shares at $2.54 ($5K) on 2026-03-31, disclosed to the SEC on 2026-04-01.
Open-market purchase of $5k PCSA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.